Looking to sell Vial stock or options?
Vial, a biotech company, aims to revolutionize drug development by focusing on hyper-scale advancements. By leveraging significantly more affordable trials and computationally designed therapeutics, Vial facilitates the progression of programs into the clinic. This approach empowers biotechnology companies to advance through various trial phases and partner with clinics to boost their revenue.
General Catalyst, TriplePoint Venture Growth BDC, Buckley Ventures, TriplePoint Capital, BoxGroup, Byers Capital.